Effects of Music and Affirmation Recital in Women With Breast Cancer
Music and Affirmation Recital on Symptom Control, Psychological Resilience and Anxiety Levels
1 other identifier
interventional
71
1 country
1
Brief Summary
The aim of this study is to determine the effect of music and affirmation recitals on symptom control, psychological resilience and anxiety levels in women with breast cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable breast-cancer
Started Oct 2024
Shorter than P25 for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 31, 2024
CompletedFirst Submitted
Initial submission to the registry
November 27, 2024
CompletedFirst Posted
Study publicly available on registry
December 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 6, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 6, 2025
CompletedFebruary 10, 2025
February 1, 2025
3 months
November 27, 2024
February 6, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Edmonton Symptom Diagnostic Scale
This scale is used to measure cancerous voice, youth, medium units, durable, anxiety, sleepiness, excitement, feeling good and shortness of breath. The measurement of the degree of feeling to be measured from the numbers 0 to 10 on a line on the scale. In the scale, 0 represents no hissing of the symptom, 10 represents very strong hissing. The Turkish validity and publication study of the scale was published by Kurt and Unsar and the Cronbach alpha value works as 0.70.
1 month
Beck Anxiety Inventory
Beck Anxiety Inventory: Developed by Beck et al. (1988) to determine the level and frequency of anxiety symptoms experienced by an individual. The scale is a Likert-type self-assessment scale consisting of 21 items and scored between 0-3. The high total score indicates the high level of anxiety experienced by the individual. The score range varies between 0-63. The scale is evaluated as 0-7 points, no anxiety symptoms, 8-15 points, mild anxiety, 16-25 points, moderate anxiety, 26-63 points, severe anxiety symptoms. The validity and reliability study in our country was conducted by Ulusoy et al. (1998) and the Cronbach alpha value of the scale was found to be 0.93.
1 month
Brief Resilience Scale
The scale was developed by Smith in 2008, and its Turkish validity and reliability study was conducted by Doğan in 2015. Brief Resilience Scale is a 5-point Likert-type self-report measurement tool consisting of 6 items. The answers are "Not at all appropriate (1), Not appropriate (2), Somewhat appropriate (3), Appropriate (4), Completely appropriate (5)". Items 2, 4, and 6 of the scale are reverse coded. The score obtained from the scale varies between 1 and 30. High scores obtained indicate high psychological resilience. In the validity and reliability study, the Cronbach alpha reliability value of the scale was found to be 0.83.
1 month
Study Arms (3)
Experimental (Music)
EXPERIMENTALAudio recordings consisting of pentatonic music and neva makam will be uploaded to the patients' phones by the researcher. Patients will be advised to listen to these music during the period they receive chemotherapy, and they will also be asked to listen to these music in at least 15-20 minute sessions per day and for at least 3 days during the week following chemotherapy.
Experimental (Affirmation)
EXPERIMENTALPatients in this group will be asked to listen to the audio recording with pentatonic music and neva makam in the background, along with the affirmation sentences provided in the appendix. Patients will be advised to listen to these music during the period they receive chemotherapy, and they will also be asked to listen to these music in at least 15-20 minute sessions per day and for at least 3 days during the week following chemotherapy.
Control
NO INTERVENTIONNo application will be made to these patients, and standard care practices will be continued.
Interventions
Audio recordings consisting of pentatonic music and neva makam will be uploaded to the patients' phones by the researcher. Patients will be advised to listen to these music during the period they receive chemotherapy, and they will also be asked to listen to these music in at least 15-20 minute sessions per day and for at least 3 days during the week following chemotherapy.
Patients in this group will be asked to listen to the audio recording with pentatonic music and neva makam in the background, along with the affirmation sentences provided in the appendix. Patients will be advised to listen to these music during the period they receive chemotherapy, and they will also be asked to listen to these music in at least 15-20 minute sessions per day and for at least 3 days during the week following chemotherapy.
Eligibility Criteria
You may qualify if:
- Those diagnosed with breast cancer
- Those who have received at least 1 course of chemotherapy
- Those over the age of 18
- Those who agree to participate in the study
You may not qualify if:
- Those who are not receiving curative chemotherapy
- Those who do not have a phone to listen to music and affirmations
- Those who do not agree to participate in the study
- Those with mental and neuropsychiatric diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Amasya University
Amasya, Turkey (Türkiye)
Related Publications (1)
Uysal N, Unal Toprak F, Sahingoz Alpargan M. The effect of music and affirmation listening on symptom management, psychological resilience, and anxiety levels in women with breast cancer. Support Care Cancer. 2025 Oct 28;33(11):984. doi: 10.1007/s00520-025-10061-3.
PMID: 41145719DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 27, 2024
First Posted
December 3, 2024
Study Start
October 31, 2024
Primary Completion
February 6, 2025
Study Completion
February 6, 2025
Last Updated
February 10, 2025
Record last verified: 2025-02